| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PNAS..108.2587K |
| P356 | DOI | 10.1073/PNAS.1013855108 |
| P932 | PMC publication ID | 3038768 |
| P698 | PubMed publication ID | 21262808 |
| P5875 | ResearchGate publication ID | 49781526 |
| P50 | author | Mark Bear | Q30223761 |
| Emily Osterweil | Q31229455 | ||
| Dilja Krueger-Burg | Q40769447 | ||
| P2093 | author name string | Lynne D Tye | |
| Stephanie P Chen | |||
| P2860 | cites work | Correction of fragile X syndrome in mice. | Q22251255 |
| The Autistic Neuron: Troubled Translation? | Q22252314 | ||
| Altered synaptic plasticity in a mouse model of fragile X mental retardation | Q24530695 | ||
| Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function | Q24608468 | ||
| Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. | Q24648260 | ||
| Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits | Q24657867 | ||
| A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability | Q28116039 | ||
| Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization | Q28396707 | ||
| Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132 | Q28510360 | ||
| Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD | Q28585633 | ||
| The mGluR theory of fragile X mental retardation | Q29615060 | ||
| Behavioural phenotyping assays for mouse models of autism | Q29618414 | ||
| Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome | Q30500501 | ||
| Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies | Q33518804 | ||
| A new perspective on the role of the orbitofrontal cortex in adaptive behaviour | Q33714118 | ||
| Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia | Q33976994 | ||
| Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism | Q34130930 | ||
| The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry | Q34153836 | ||
| Dissociable regulation of instrumental action within mouse prefrontal cortex | Q34682980 | ||
| Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. | Q34994002 | ||
| Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates | Q35957721 | ||
| Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans | Q36424868 | ||
| The pathophysiology of fragile x syndrome. | Q36810319 | ||
| Fragile X syndrome: assessment and treatment implications | Q36846987 | ||
| The regulation and function of c-fos and other immediate early genes in the nervous system | Q37583743 | ||
| Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome | Q38507466 | ||
| Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities | Q42042937 | ||
| Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice | Q42620608 | ||
| Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. | Q43892381 | ||
| Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model | Q44913676 | ||
| Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex | Q45041368 | ||
| FMRP acts as a key messenger for dopamine modulation in the forebrain | Q46400113 | ||
| Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse. | Q46497187 | ||
| Biochemical characterization of a filtered synaptoneurosome preparation from guinea pig cerebral cortex: cyclic adenosine 3':5'-monophosphate-generating systems, receptors, and enzymes | Q46518846 | ||
| Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. | Q46626541 | ||
| A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome. | Q46726655 | ||
| Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1. | Q48158558 | ||
| Mildly impaired water maze performance in male Fmr1 knockout mice | Q48818692 | ||
| Visual search in typically developing toddlers and toddlers with Fragile X or Williams syndrome. | Q51938149 | ||
| Further delineation of the executive deficit in males with fragile-X syndrome. | Q52121725 | ||
| Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium | Q72065437 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fragile X syndrome | Q221472 |
| cognitive dysfunction | Q57859955 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 2587-2592 | |
| P577 | publication date | 2011-01-24 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome | |
| P478 | volume | 108 |
| Q35317895 | Aberrant frontal lobe maturation in adolescents with fragile X syndrome is related to delayed cognitive maturation |
| Q41270458 | Age-Dependent Long-Term Potentiation Deficits in the Prefrontal Cortex of the Fmr1 Knockout Mouse Model of Fragile X Syndrome |
| Q47634845 | Altered attentional processing in male and female rats in a prenatal valproic acid exposure model of autism spectrum disorder. |
| Q37381870 | Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome |
| Q45986799 | Caspase-3 deficiency results in disrupted synaptic homeostasis and impaired attention control. |
| Q42054553 | Cell-Type Specific Channelopathies in the Prefrontal Cortex of the fmr1-/y Mouse Model of Fragile X Syndrome. |
| Q35035766 | Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome |
| Q50583805 | Chemicogenetic Restoration of the Prefrontal Cortex to Amygdala Pathway Ameliorates Stress-Induced Deficits. |
| Q30458768 | Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders |
| Q24613296 | Conceptualizing neurodevelopmental disorders through a mechanistic understanding of fragile X syndrome and Williams syndrome |
| Q47723867 | Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments |
| Q47795409 | Decreased home cage movement and oromotor impairments in adult Fmr1-KO mice. |
| Q64084225 | Deletion of the KH1 Domain of Fmr1 Leads to Transcriptional Alterations and Attentional Deficits in Rats |
| Q48665243 | Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse. |
| Q40142644 | Disrupted Cortical State Regulation in a Rat Model of Fragile X Syndrome. |
| Q36371362 | Dynamic regulation of synaptic maturation state by voltage-gated A-type K+ channels in CA1 hippocampal pyramidal neurons |
| Q96303147 | Dysregulated Prefrontal Cortex Inhibition in Prepubescent and Adolescent Fragile X Mouse Model |
| Q37372367 | Effects of stimulus salience on touchscreen serial reversal learning in a mouse model of fragile X syndrome |
| Q37694175 | Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders |
| Q50066459 | Enhanced operant extinction and prefrontal excitability in a mouse model of Angelman syndrome |
| Q38607739 | Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics |
| Q61814927 | Executive Function in Fragile X Syndrome: A Systematic Review |
| Q34276734 | Extinction of an instrumental response: a cognitive behavioral assay in Fmr1 knockout mice |
| Q38097197 | Fragile X mental retardation protein and synaptic plasticity |
| Q54782597 | Fragile X syndrome: From protein function to therapy. |
| Q38162720 | Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development |
| Q34292108 | Fragile X syndrome: an update on developing treatment modalities |
| Q30410502 | From FMRP function to potential therapies for fragile X syndrome |
| Q35218838 | Functional and structural deficits at accumbens synapses in a mouse model of Fragile X. |
| Q35492486 | Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome |
| Q36305963 | Group I mGluR antagonist rescues the deficit of D1-induced LTP in a mouse model of fragile X syndrome |
| Q36361892 | Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases. |
| Q91055005 | Hippocampal spike-time correlations and place field overlaps during open field foraging |
| Q47706214 | Hotspots of dendritic spine turnover facilitate clustered spine addition and learning and memory |
| Q30557514 | Hyperactivity, perseveration and increased responding during attentional rule acquisition in the Fragile X mouse model |
| Q30376404 | Impaired Dendritic Development and Memory in Sorbs2 Knock-Out Mice. |
| Q30713841 | Impaired cognitive discrimination and discoordination of coupled theta-gamma oscillations in Fmr1 knockout mice |
| Q35794883 | Impaired survival of neural progenitor cells in dentate gyrus of adult mice lacking fMRP |
| Q35688627 | In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation |
| Q47759226 | Increased transient Na+ conductance and action potential output in layer 2/3 prefrontal cortex neurons of the fmr1-/y mouse. |
| Q34435526 | Increasing our understanding of human cognition through the study of Fragile X Syndrome |
| Q35674710 | Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome |
| Q92021406 | Intellectual disability and autism spectrum disorders 'on the fly': insights from Drosophila |
| Q37535064 | Late onset deficits in synaptic plasticity in the valproic acid rat model of autism |
| Q26866506 | Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us. |
| Q47241090 | Male-specific deficits in natural reward learning in a mouse model of neurodevelopmental disorders |
| Q30447994 | Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? |
| Q36026916 | Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. |
| Q30420595 | Modeling fragile X syndrome in the Fmr1 knockout mouse |
| Q37126507 | Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity |
| Q26853035 | Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders |
| Q36598019 | Neuroligin-2 and the tightrope of excitation/inhibition balance in the prefrontal cortex |
| Q27015370 | Neuroligins provide molecular links between syndromic and nonsyndromic autism |
| Q28512874 | Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory |
| Q47553088 | Normal CA1 Place Fields but Discoordinated Network Discharge in a Fmr1-Null Mouse Model of Fragile X Syndrome |
| Q30387508 | Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task |
| Q42098963 | Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome. |
| Q50026702 | Perturbation of GABAergic Synapses at the Axon Initial Segment of Basolateral Amygdala Induces Trans-regional Metaplasticity at the Medial Prefrontal Cortex |
| Q38708008 | Prefrontal Cortex Dysfunction in Fragile X Mice Depends on the Continued Absence of Fragile X Mental Retardation Protein in the Adult Brain. |
| Q64096115 | Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice |
| Q34499370 | Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice. |
| Q37685418 | Regulation of mRNA transport, localization and translation in the nervous system of mammals (Review). |
| Q47723002 | Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice |
| Q42512974 | Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. |
| Q92801198 | Reward-Related Expectations Trigger Dendritic Spine Plasticity in the Mouse Ventrolateral Orbitofrontal Cortex |
| Q41170329 | Sequence of Molecular Events during the Maturation of the Developing Mouse Prefrontal Cortex |
| Q48087238 | Spontaneous Neuronal Network Persistent Activity in the Neocortex: A(n) (Endo)phenotype of Brain (Patho)physiology |
| Q26768226 | Striatal Circuits as a Common Node for Autism Pathophysiology |
| Q36179820 | Synaptic NMDA receptor-mediated currents in anterior piriform cortex are reduced in the adult fragile X mouse |
| Q27023257 | Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes |
| Q90795216 | The RNA binding protein fragile X mental retardation protein promotes myelin sheath growth |
| Q37559828 | The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome. |
| Q38098906 | The translation of translational control by FMRP: therapeutic targets for FXS. |
| Q27337360 | Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back |
| Q35614072 | Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond |
| Q99555072 | Visual Sequences Drive Experience-Dependent Plasticity in Mouse Anterior Cingulate Cortex |
| Q35230774 | Visual sensorial impairments in neurodevelopmental disorders: evidence for a retinal phenotype in Fragile X Syndrome |
Search more.